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Abstract
Post-translational modifications of connexins play an important role in the regulation of gap junction and hemichannel
permeability. The prerequisite for the formation of functional gap junction channels is the assembly of connexin
proteins into hemichannels and their insertion into the membrane. Hemichannels can affect cellular processes by
enabling the passage of signaling molecules between the intracellular and extracellular space. For the intercellular
communication hemichannels from one cell have to dock to its counterparts on the opposing membrane of an
adjacent cell to allow the transmission of signals via gap junctions from one cell to the other. The controlled
opening of hemichannels and gating properties of complete gap junctions can be regulated via post-translational
modifications of connexins. Not only channel gating, but also connexin trafficking and assembly into hemichannels
can be affected by post-translational changes. Recent investigations have shown that connexins can be modified by
phosphorylation/dephosphorylation, redox-related changes including effects of nitric oxide (NO), hydrogen sulfide
(H2S) or carbon monoxide (CO), acetylation, methylation or ubiquitination. Most of the connexin isoforms are known
to be phosphorylated, e.g. Cx43, one of the most studied connexin at all, has 21 reported phosphorylation sites. In this
review, we provide an overview about the current knowledge and relevant research of responsible kinases, connexin
phosphorylation sites and reported effects on gap junction and hemichannel regulation. Regarding the effects of
oxidants we discuss the role of NO in different cell types and tissues and recent studies about modifications of
connexins by CO and H2S.
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Background
Connexins (Cxs), a protein family with 21 members in
humans, share some important functional and structural
characteristics. Thus, Cxs are catalogued as transmem-
brane proteins, containing four transmembranous do-
mains, two extracellular loops, one cytoplasmic loop and
both cytoplasmic N- and C-terminal domains facing the
cytoplasm. To constitute a gap junction (GJ) channel, six
Cx subunits first assemble into a hemichannel (HC), also
known as connexon that docks to another HC located in
a neighbouring cell to finally form an intercellular GJ
channel [1]. GJs allow the diffusion of ions, second
messengers and small molecules up to ~1.8 kDa be-
tween adjacent cells [2, 3], whereas HCs allow the ex-
change of small molecules between the cytoplasm and
the extracellular space [4–6]. The life cycle of Cxs, their
cellular transport, GJ assembly, stability, degradation,
the channel gating and selectivity properties are regu-
lated via post-translational modifications and interactions
with other cellular proteins [7–9]. Because phosphoryl-
ation and oxidation/reduction associated processes are
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found widely in all tissues, we will summarize and discuss
the current knowledge of these two mechanisms on the
regulation of GJs and HCs.
Regulation of GJs and HCs by phosphorylation
Cxs have multiple phosphorylation sites, e.g. 21 of
these sites have been described for Cx43 [7, 8]. The
phosphorylation of Cxs occurs primarily at the C-terminal
region, but Cx36 and Cx56 can also be phosphorylated
within the cytoplasmic loop [10, 11]. The very short Cx26
has a C-terminal region with only 11 amino acids and was
believed to be a non-phospho-protein since a phosphoryl-
ation in this protein was not detectable in hepatocytes
[12]. Many years later Locke et al. found a possible phos-
phorylation site at the Cx26 N-terminal region using HeLa
cells as exogenous expression system, but phosphorylation
of Cx26 in cells that endogenously express this protein,
like in liver cells, has not be detected yet [13, 14]. The for-
mation of functional GJs does not seem to require Cx
phosphorylation since truncated Cx43 lacking most of the
cytoplasmic C-terminal region were still able to form
functional GJs, albeit with different conductance than
those formed by wild-type Cx43 [15, 16].
Post-translational phosphorylation of Cxs can regu-
late channel properties of both HCs and GJs [17].
Additionally, Cx phosphorylation also correlates with
changes of Cx trafficking, GJ assembly and stability
[8, 18–20]. Phosphorylation of Cxs occurs at different
stages of the Cx life cycle [21]. As typical integral
membrane proteins, Cxs are synthesized in the endo-
plasmic reticulum (ER), and depending of the Cx type
they can pass or not through the Golgi network, form
HCs and move to the plasma membrane where they
build GJ structures [2, 22]. By far the most extensively
studied Cx is Cx43, which is widely and predominantly
expressed in mammalian cells [7, 8].
Regulation of GJs by phosphorylation
The half-life of Cx43 has been reported to be about 5 h
in liver hepatocytes and 1.3 h in the heart [19, 23].
Cx43 phosphorylation by protein kinase p34cdc2 has
been linked to GJ internalization at the onset of mitosis
[19]. Turnover, internalization and degradation are
highly associated with phosphorylation/dephosphoryla-
tion events and can be triggered by a variety of stimuli
(e.g., growth factors, extracellular matrix interactions,
ischemia, wounding, inflammation, etc.) [9, 19]. These
phosphorylation changes are related with changes in
the gap junction intercellular communication (GJIC)
and may be necessary for normal cell cycling [19].
Therefore, this GJ turnover is apparently a response to
environmental conditions with increasing or decreasing
GJIC rates [24].
Gating kinetics of GJ channels can be modulated in a
rapid and reversible manner by direct phosphorylation
of Cxs, which changes the extent of GJIC. GJs can
thereby undergo conformational changes in order to
modify channel gating as described in the “ball and
chain”, “cork gating” or “particle-receptor” models [25].
The phosphorylation enables the C-terminal region to
interact with either the pore-forming region or an inter-
mediary molecule to form a complex that results in
channel closure [25].
In general, the phosphorylation of Cxs can occur
through serine/threonine kinases or tyrosine kinases.
Among the serine/threonine kinases that phosphoryl-
ate Cxs are e.g. protein kinase C (PKC), MAP kinase
(MAPK), cAMP-dependent protein kinase A (PKA),
casein kinase (CK), p34cdc2, protein kinase G (PKG),
Ca2+/calmodulin-dependent kinase II (CaMKII), but
also the tyrosine kinase Src is able to phosphorylate
Cxs [7, 18]. Some residues may be targets for mul-
tiple protein kinases implying varying influences on
GJs under different physiological or pathophysiological
conditions [26]. Reported phosphorylation sites of
connexins, responsible kinases and the effect on GJs
are summarized in Table 1 and for Cx43 shown in Fig. 1.
Phosphorylation of connexins by serine/threonine kinases
and its effect on GJs
cAMP-dependent protein kinase A (PKA)
In a variety of cell populations, an increase of cAMP
concentration is correlated with an upregulation of
GJIC, but there are also reports showing that cAMP in-
creases had an inhibitory effect or no effects upon GJIC
[27]. For Cx43, it has been demonstrated that elevated
intracellular levels of cAMP increased GJIC in different
systems [28–31]. Paulson et al. have shown that elevated
levels of cAMP enhanced the membrane trafficking of
Cx43 and could trigger a rapid GJ assembly at the cell
surface [27]. The increased GJ assembly involved the ac-
tivation of PKA and phosphorylation of Cx43 at Ser364
as shown in a study of TenBroek et al. [32]. The treat-
ment of primary granulosa cells with follicle-stimulating
hormone (FSH), which increases the intracellular level of
cAMP, induced the phosphorylation of Cx43 at Ser365,
Ser368, Ser369 and Ser373 [33]. It is therefore conceiv-
able that these phosphorylation events occur in a PKA
dependent way [33]. While Ser364 is phosphorylated by
PKA [32], Ser365 can be phosphorylated either by PKA
or PKC [7]. Shah et al. have found that Cx43 is a rela-
tively poor substrate of PKA compared to PKC, but the
phosphorylation at Ser364 by PKA seems to be import-
ant for subsequent phosphorylation of Cx43 by PKC
[34]. In addition, also other Cx types are phosphorylated
by PKA. Thus, in vivo phosphorylation of Cx50 (Ser395)
by PKA in chicken lens has been shown to promote dye
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permeability of Cx50 GJs and appears therefore to be
important for metabolic coupling and transport in lens
fibers [35]. The PKA dependent in vitro phosphorylation
of Cx32 (at Ser233) in hepatocytes was associated with
an increase in GJIC [18, 36, 37].
A negative regulation by PKA was reported for GJs
formed by Cx35. In HeLa cells expressing Cx35, the ap-
plication of a PKA activator reduced GJIC, while a PKA
inhibitor increased GJIC [38]. In vitro phosphorylation
studies showed that PKA phosphorylates Cx35 at
Ser110 (in the intracellular loop) and Ser276 (in the
carboxyl terminus) [38, 39]. A study from Li and col-
leagues showed that PKA phosphorylated Cx35 directly in
photoreceptors and increased GJIC [40]. The explanation
for these apparently contradictory findings of PKA to re-
duce Cx35-GJIC comes from a study of Kothmann et al.
They demonstrated that the dopamine induced uncoup-
ling of AII amacrine cells resulted from PKA activation of
protein phosphatase 2A (PPA2) and subsequent dephos-
phorylation of Cx35 [41]. These results suggest that the ef-
fect of PKA activity on Cx35 GJIC can be positively
affected by PKA dependent phosphorylation of Cx35 and
negatively regulated by PKA dependent activation of
PPA2 and subsequent dephosphorylation of Cx35.
A role for PKA in the regulation of GJIC was also re-
ported for Cx40. Administration of cAMP resulted in a
Table 1 Reported phosphorylation sites of connexins, responsible kinases and the effect on gap junctions
Kinases Connexins Phosphorylated residues Reported effects on GJs References
PKA Cx32 Ser233 increased GJIC [18, 36, 37]
Cx35/36 Ser110, Ser276 reduced GJIC [38–41]
increased GJIC
Cx40 n/a increased GJIC [42, 43]
Cx43 serines 364, 365, 368, 369, 373 rapid GJ assembly, increased GJIC [7, 27–34]
Cx50 Ser395 increased GJIC [35]
AKT (PKB) Cx43 Ser373 increased GJ size and GJIC [44]
Cx50 n/a increased GJIC [45]
PKC Cx43 serines 365, 368, 369, 372, 373 decreased GJ assembly, decreased
GJIC, reduced half-life of Cx43, in
ischemic hearts decreased coupling
by Ser368 phosphorylation (56) or
de-phosphorylation (55)
[7, 18, 46–56]
Cx32 Ser233 n/a [18, 37, 57]
Cx56 chicken homologue
of Cx46
Ser118 decreased GJIC [11, 18, 58]
PKG Cx35/36 Ser110, Ser276, Ser289 decreased GJIC [59]
CaMKII Cx43 serines 244, 255, 257, 296, 297, 306,
314, 325, 328, 330, 364, 365, 369,
372, 373
de-phosphorylation of Ser306 during
ischemia reduced GJIC (62)
[60–63]
Cx32 n/a n/a [37]
Cx36 n/a increased GJIC [64–66]
Cx45 Ser326, Thr337, serines 381, 382, 384,
385, 387, 393
n/a [67]
CK1 Cx43 serines 325, 328, 330 increased GJ assembly [26]
Cx45 serines 326, 382, 384, 387, 393 n/a [67]




P34cdc2 Cx43 Ser255, Ser262 GJ internalization [70, 71]
MAPK Cx43 serines 255, 262, 279, 282 GJ internalization, decreased GJIC [54, 70, 72–75]
Cx50 n/a n/a [76]
Src Cx43 Tyr 247, 265 reduced GJIC [77–79]
EGFR tyrosine kinase Cx32 Tyr 243 n/a [82]
n/a, not applicable
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mobility shift of Cx40 on western blot and increased
the permeability of GJs formed by Cx40 in transfected
SKHep1 cells [42]. Moreover, a study of Bolon et al.
demonstrated that lipopolysaccharide (LPS) and hyp-
oxia/reoxygenation (H/R) reduced GJIC of wild-type
microvascular endothelial cells but not in Cx40 null
cells, and this was associated with a decreased PKA
specific phosphorylation of Cx40 [43].
AKT (PKB)
AKT dependent phosphorylation of Cx43 at Ser373
increased GJ size and communication by preventing
the binding of ZO-1 to Cx43 [44]. Phosphorylation of
Ser373 was mainly observed in larger gap junctional
structures at the membrane and was increased in epi-
thelial cells and skin or heart tissue after wounding
or hypoxia. This phosphorylation site might therefore
act as a molecular switch to increase GJIC under
these conditions [44]. A potential regulation of Cx50
but not Cx46 by PI3K signaling has been described in
a study of Martínez and colleagues [45]. They demon-
strated that PI3K/AKT activation upregulated Cx50
GJ conductance whereas inhibition of PI3K or AKT
decreased Cx50 mediated GJ conductance [45].
Protein kinase C (PKC)
A PKC dependent phosphorylation of Cxs has been
shown to affect GJIC in a negative manner decreasing
GJ conductance or reducing dye coupling [18, 46]. The
phosphorylation of Cx43 by PKC has been demonstrated
by different groups and involves the amino acids Ser365,
368, Ser369, Ser372 and Ser373 [7, 46–49]. It has been
shown in many different cell types that the activation of
PKC increased the phosphorylation of Cx43, which was
associated with decreased GJ assembly, downregulation
of GJIC and a reduced half-life of Cx43 [18, 50]. A cor-
relation between PKC dependent Ser368 phosphoryl-
ation of Cx43 and decreased GJIC has been reported by
several groups [47, 48, 51–53]. For example, Liao et al.
showed that Ser368 phosphorylation by PKC was ac-
companied by a loss of Cx43 from GJs, an increased ubi-
quitination of Cx43 and reduced GJIC [51]. This was
confirmed by Wang et al., who found an increased
localization of Cx43 in the membrane and enhanced
GJIC when PKC mediated Ser368 phosphorylation of
Fig. 1 Post-translational modified sites of Cx43
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Cx43 was inhibited [52, 53]. The effect of the tumor-
promoting phorbol ester 12-O-tetradecanoylphorbol 13-
acetate (TPA) on Cx43 GJs was reported by Sirnes and
colleagues [54]. They demonstrated that the TPA in-
duced inhibition of GJIC was dependent on Cx43 phos-
phorylation not only by PKC on Ser368, but also by
MAPKs on Ser255 and Ser262 [54].
The role of Ser368 phosphorylation of Cx43 on the
electrical conductance during myocardial ischemia
does not appear to be sufficiently clear. A study by
Axelsen and colleagues demonstrated that Ser368 be-
came dephosphorylated during ischemia in isolated
rat hearts and that was associated with a similar de-
crease in electrical coupling [55]. A preservation of
Ser368 phosphorylation should therefore contribute to
an improved electrical coupling during ischemia [55].
However, Ek-Vitorin and colleagues found a reduced
GJ conductance with increased phosphorylation of
Ser368 in Cx43 during ischemia in excised mice
hearts [56]. Further research may clarify the role of
Ser368 phosphorylation and will explain these contra-
dictory findings.
The phosphorylation of Cx32 at Ser233 in a PKC
dependent manner has been described in freshly
isolated hepatocytes [18, 37, 57]. This amino acid can
additionally be phosphorylated by PKA [37]. In
chicken lens cultures expressing Cx56 (the chicken
homologue of Cx46) the treatment with TPA resulted
in an increased phosphorylation at Ser118 of the
intracellular loop of Cx56 in a PKC dependent manner
[11]. Moreover, the TPA-dependent phosphorylation of
Ser118 decreased GJIC and accelerated degradation of
Cx56 [11, 18, 58].
Protein kinase G (PKG)
Cx35 (the fish ortholog of mammalian Cx36), that is
expressed in neurons, can be phosphorylated by PKG
[59]. In vitro studies with stably transfected HeLa
cells identified three PKG phosphorylation sites in
Cx35: Ser110 (within the intracellular loop), Ser276
and Ser289 (within the C-terminal tail). The PKG
dependent phosphorylation of Cx35 was regulated by
NO that can induce the activation of soluble guanylyl
cyclase/cGMP/PKG [59]. Both, application of NO donors
or activation of PKG in the absence of exogenous NO
caused Cx35-mediated uncoupling in HeLa cells [59].
Ca2+/calmodulin kinase II (CaMKII)
Ca2+/calmodulin kinase II plays a critical role in the
regulation of Ca2+ homeostasis, transcription and apop-
tosis, as well as in ischemic heart diseases. In cardiac
diseases, such as heart failure or myocardial ischemia
and infarction, an increased expression or activation of
CaMKII has been shown [60]. Calmodulin (CaM) can
modulate GJ gating properties by activating CaMKII or
by direct interaction with the Cx proteins mediating
Ca2+-induced uncoupling of GJs. The GJ inhibition by
Ca2+-CaM can be prevented by CaM blockers or CaM
antagonists [61]. A co-localization of CaMKII with
Cx43 has been found at the border zone of infarcted
hearts [62]. Huang and colleagues identified 15 serine
phosphorylation sites for CaMKII in the carboxyl
terminus of Cx43. They investigated the phosphoryl-
ation of Cx43 by CaMKII in vitro using fusion proteins
containing the C-terminal region of Cx43. The serine
residues 244, 255, 257, 296, 297, 306, 314, 325, 328,
330, 364, 365, 369, 372 and 373 were identified by mass
spectrometry as putative in vitro phosphorylation tar-
gets of CaMKII [60]. Dephosphorylation of Ser306 has
been shown during ischemia in rat hearts and contrib-
utes to a reduced coupling [63]. Phosphorylation of
Cx43 at Ser325/328/330 was previously shown by
Cooper and Lampe, but in a CK1 mediated manner
[26]. Cx32 can also be phosphorylated by CaMKII in
addition to PKA and PKC, as demonstrated by Sáez et
al., in purified liver GJs and in hepatocytes [37]. An
interaction of Cx36 with CaMKII and its phosphoryl-
ation by CaMKII was demonstrated by Alev and col-
leagues [64]. They identified two binding sites of
CaMKII at the cytoplasmic loop and close to the
carboxyl-terminal region of Cx36 [64]. An increased GJ
conductance has been shown to correlate with in-
creased intracellular Ca2+ levels that induced the activa-
tion of CaMKII. Therefore, the enhancement of the GJ
conductance could be mediated by a phosphorylation
of Cx36 by CaMKII [65, 66]. Also Cx45 can be phos-
phorylated by CaMKII as well as by CK1 as demon-
strated by Bao and co-workers. They identified eight
Ser/Thr residues (Ser326, Thr337, serines 381, 382,
384, 385, 387 and 393), that were phosphorylated by
CaMKII by mass spectrometry [67]. Some of these
residues are also targets of CK1 (Ser326, 382, 384,
387 and 393) [67]. It remains to be elucidated,
whether these residues are indeed phosphorylated
in vivo and how they may affect GJIC and/or GJ as-
sembly [67].
Casein kinase (CK)
Phosphorylation of Cx43 by CK1 at Ser325, Ser328 and
Ser330 has been reported to promote GJ assembly [26].
As mentioned above, CK1 can also phosphorylate Cx45
at Ser326, 382, 384, 387 and 393, as shown by Bao et al.
[67]. On the other hand, Yin et al. reported that Cx45.6
(the avian ortholog of mammalian Cx50) is phosphory-
lated by CK2 in vitro at Ser363, but not by CK1 and they
also observed that this phosphorylation event led to
destabilization and degradation of Cx45.6 [68].
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Cyclin-dependent kinase 5 (Cdk5)
Cdk5 is involved in developmental processes of the
brain. Cdk5 directly phosphorylates Cx43 at Ser279 and
Ser282 and thereby preventing the membrane targeting
of Cx43 and promoting its proteasome dependent deg-
radation [69]. Cx43 expression in neurons is involved in
regulating neuronal progenitors migration and position-
ing in the developing brain by controlling the interaction
of astrocytes with neurons [69]. Therefore, the mem-
brane localization and degradation of Cx43 in neurons
during neuronal differentiation appears to be regulated
by Cdk5 dependent phosphorylation [69].
Cyclin dependent kinase p34cdc2
Phosphorylation of Cxs during cell cycle progression
can be regulated by p34cdc2 playing an important
role for the initiation of mitosis [70]. The reduction
of GJIC during mitosis is accompanied by increased
phosphorylation of Cx43 at Ser255 and Ser262 by
p34cdc kinase activity. This cell cycle regulated phos-
phorylation of Cx43 is associated with cells rounding
and GJ internalization [70, 71].
MAPK
Serine residues 255, 262, 279/282 of Cx43 are target sites
for MAPK phosphorylation [54, 72–74]. In endothelial
cells, phosphorylation of Cx43 at Ser255, 262 and 279/282
by MAPK ERK1/2 in response to stimulation with VEGF
has been found [72]. This was associated with a rapid GJ
internalization and correlated with an inhibition of
GJIC, which was restored within 1–2 h after VEGF
treatment [72]. Also treatment with phorbol esters
(TPA), lysophosphatic acid (LPA) or EGF and subse-
quent activation of the EGF receptor induced a phos-
phorylation of Ser255, Ser262, Ser278/282 of Cx43
leading to a rapid disruption of GJIC [54, 73, 74].
Accordingly, mutations of Ser279 and 282 restored GJ
assembly [75]. Ser255 has been reported to be phos-
phorylated by both MAPK and p34cdc2 [70]. An
increased GJ coupling induced by activation of the
MAPK ERK1/2 signaling has been demonstrated in
paired Xenopus oocytes and primary lens epithelial
cells [76]. In these cells the enhanced coupling was
mediated by expression of Cx50, but not Cx46. How-
ever, it remains unclear whether Cx50 becomes
directly phosphorylated by MAPKs or indirectly via
other kinases activated by the MAPK pathway [76].
Phosphorylation of Cxs by tyrosine kinases and its effect
on GJIC
Activation of the oncogene and tyrosine kinase Src
leads to acute down-regulation of GJIC [77]. Src can
affect GJs in different ways, as shown for Cx43 either
by a direct tyrosine phosphorylation or by activating
downstream effector kinase pathways [78]. Lin and
colleagues proposed a model for the interaction of
Cx43 with Src and its phosphorylation by Src leading
to the disruption of the GJIC [79]. At first, the SH3
domain of Src binds to the proline rich region of
Cx43 (Pro274-Pro282) that brings the kinase domain
of Src close to Tyr265. The phosphorylated Tyr265
facilitates the binding of the SH2 domain of Src that
stabilizes the interaction of Cx43 and Src. The en-
hanced interaction induces the phosphorylation of
Tyr247, which triggers the closure of GJs built by
Cx43 [79].
Additionally, an indirect influence of Src on GJIC via
Src effector kinases has been shown, e.g. for MAPK,
PI3K/Akt and PKC signaling pathways [78]. Chronic un-
coupling in response to v-Src has been linked to a direct
tyrosine phosphorylation of Tyr265 and 247 of Cx43,
whereas a serine phosphorylation of Cx43 associated with
Src expression does not seem to be essential for long term
uncoupling. The acute closure of GJs immediately after
Src expression in a “ball and chain” mechanism is not as-
sociated with a Src dependent tyrosine phosphorylation,
but it is mediated by serine phosphorylation of Cx43 at
Ser255, 279, 282 by ERK1/2 [80, 81]. The phosphorylation
of Cxs by other tyrosine kinases has been shown for Cx32.
Diez et al. found a phosphorylation at Tyr243 by the epi-
dermal growth factor receptor tyrosine kinase [82].
Regulation of HCs by phosphorylation
Despite the large number of kinases that phosphorylate
Cxs, only PKA, PKC, MAPK and Akt activity have been
found to regulate the HC activity [47, 83–88]. Reported
phosphorylation sites of connexins, responsible kinases
and the effect on HCs are summarized in Table 2 and
for Cx43 shown in Fig. 1.
Table 2 Reported phosphorylation sites of connexins, responsible kinases and the effect on hemichannels
Kinases Connexins Phosphorylated residues Reported effects on HCs References
PKA Cx35/36 n/a reduced HC permeability [89, 90]
AKT (PKB) Cx43 Ser369, Ser373 increased HC permeability [85, 88]
Cx26 n/a increased HC permeability [92]
PKC Cx43 Ser368 reduced HC permeability [47, 83, 84, 86, 93]
MAPK Cx43 serines 255, 262, 279, 282 reduced HC permeability [54, 74, 87]
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cAMP-dependent protein kinase A (PKA)
A few studies have shown that also neuronal HC activity
can be controlled by phosphorylation of Cxs. Mitropou-
lou and colleagues could demonstrate that HCs formed
by Cx35 can be regulated by cAMP/PKA. They injected
two different fish Cx35 RNAs (from perch and skate)
into Xenopus oocytes to investigate dopamine induced
PKA signaling on HC functions. The incubation with
cAMP caused a dose-dependent inhibition of voltage-
activated HC currents only in the presence of perch but
not of skate Cx35 [89]. Amino acid sequence compari-
son revealed that in skate Cx35 the PKA consensus se-
quence was absent. The PKA dependent inhibition of
HC activity was confirmed by site-directed mutations
of the PKA phosphorylation site [89]. DeVries and
colleagues also demonstrated that dopamine sup-
pressed HC activity in solitary horizontal cells isolated
from catfish retinas using whole-cell voltage clamp
[90]. This effect was inhibited by blocking the PKA
activity, which also suggests the importance of PKA
for dopamine induced inhibition of HC activity [90].
Since PKA also activates the phosphatase PP2A, as
discussed before for GJs, the inhibition of HC activity
could likely be the effect of Cx dephosphorylation.
AKT (PKB)
Recently it has been reported that AKT is capable of
regulating HCs, specifically those formed by Cx43
[85]. Previous studies showed that AKT was able to
phosphorylate Cx43 in vitro, specifically at Ser369
and Ser373 [91]. Batra and colleagues demonstrated
that AKT mediated phosphorylation of HC formed by
Cx43 (Cx43-HC) is critical for bone formation and
remodeling under mechanical stimulation [85]. They
showed that Cx43-HC opening induced by shear
stress was dependent on phosphorylation of Cx43 at
Ser 369/Ser373 in MLO-Y4 osteocytic cells [85].
Moreover, Cx43 mutated at this site (S369A or
S373A) failed to block shear stress induced HC open-
ing [85]. Salas and colleagues showed that metabolic
inhibition by blocking the ATP production increased
Cx43 HC activity in HeLa cells [88]. They demon-
strated that metabolic inhibition induced a rapid and
transient activation of AKT that was necessary to in-
crease the number or expression of Cx43-HCs on the
cell surface. The inhibition of AKT or the expression
of mutated Cx43 (S373A) reduced the activity of
Cx43-HCs [88]. However, Figueroa and colleagues
demonstrated that linoleic acid increased Cx26-HC
opening by activation of PI3K/AKT, because specific
PI3K/AKT inhibitors reduced Cx26-HC opening [92].
Whether these HC changes are mediated via phos-
phorylation of Cx26 is not clear yet [92].
Protein kinase C (PKC)
It is well documented that inhibition of PKC increases
the Cx43-HC activity [47, 83, 84, 86]. Studies in Xenopus
oocytes expressing recombinant Cx43 showed that fluor-
escent dye (5(6)-carboxyfluorescein) uptake via HCs was
increased by different blockers of PKC activity (calphos-
tin C, bisindolylmaleimide or chelerythrine) [47]. The
amino acid Ser368 has been identified as regulatory site
of PKC in Cx43-HC [47, 83, 84]. HCs formed by Cx43
mutated at serine 368 (S368A) were not permeable to
sucrose or Lucifer yellow [47, 83, 84]. Permeability as-
says performed with proteoliposomes loaded with radi-
olabelled probes revealed that phosphorylation of all
Cx43 subunits by PKC inhibited the HC permeability to
large but not to small hydrophilic solutes [83]. It also
has been demonstrated that chelerythrine, a specific in-
hibitor of PKC, prevented the inhibitory effect of throm-
bin on the uptake of lucifer yellow in cultured bovine
corneal endothelial cells [93]. Other studies performed
in tsA201 cells (a cell line derived from human embry-
onic kidney cells) that expressed recombinant Cx43,
showed that phorbol 12-myristate 13-acetate (PMA)
inhibited the macroscopic Cx43-HC conductance [86].
This effect was prevented by bisindolylmaleimide, a spe-
cific inhibitor of PKC activity [86]. The treatment with
bisindolylmaleimide also increased the total membrane
current in Cx43 expressing tsA201 cells [86]. In
addition, Hawat and colleagues showed that conven-
tional and novel PKC isoforms are involved in the regu-
lation of Cx43 HCs [86].
MAPK
In vitro studies showed that MAPK phosphorylated
Ser255, Ser262, Ser279, and Ser282 of Cx43 [54, 74].
Subsequently, functional studies in lipid vesicles con-
taining Cx43-HCs pre-loaded with fluorescent probes
(e.g., LY) showed that Cx43-HCs were regulated by
MAPK phosphorylation [87]. Kim and colleagues
demonstrated that phosphorylation of Cx43 by MAPK
reduced the permeability of liposomes containing de-
phosphorylated Cx43 [87].
Regulation of GJs and HCs by the redox potential
Changes in the redox potential are probably the broadest
control mechanism of ion channels under physiological
and pathological conditions [94]. Several ion channels
are regulated by one or more oxidant or reducing mole-
cules, including Cxs [95]. Among the large number of
oxidant molecules that modulate ion channels, in this
review we will focus on three gaseous transmitters so far
characterized: nitric oxide (NO), carbon monoxide (CO),
hydrogen sulfide (H2S) [96], and their effects on GJ
channels and HC properties. Regarding the oxidant gas,
sulfur dioxide (SO2) [97], to our knowledge there are no
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reports about its role in modulating the permeability of
Cx based channels. Reported sites of Cx43 affected by
the redox potential are shown in Fig. 1.
Regulation of GJs by nitric oxide
NO is a gaseous transmitter that is formed by the action
of an enzyme family known as nitric oxide synthases
(NOS) [98]. There are three isoforms of this enzyme, the
endothelial NO synthase (eNOS), mainly expressed in
endothelial cells, the neuronal NO synthase (nNOS),
largely expressed in nervous tissues, and an inducible
one (iNOS), expressed by cells in response to tissue
damage [99, 100]. Once produced by the cells, NO
can diffuse to neighboring cells and act in two pos-
sible ways: i) directly through the S-nitrosylation of
cysteine groups [101–103] and ii) indirectly through
activation of the guanylyl cyclase, which in turn increases
the cGMP levels activating the PKG [103, 104]. In the case
of S-nitrosylation, NO effects can be mediated by
direct S-nitrosylation of the Cx itself or indirectly by
S-nitrosylation of proteins involved in post-translational
modifications of the Cx (e.g. kinases or phosphatases)
[105]. S-nitrosylation of kinases or phosphatases can affect
many signal transduction pathways and often leads to an
inhibition of the enzyme activity (e.g., ASK1, JNK, Akt,
PKC, IkB, SHP1 and SHP2), but to the contrary kinase
activation (e.g., cSrc or glucokinase) has also been de-
scribed [105]. Several kinases known to phosphorylate
Cxs can be regulated via S-nitrosylation, e.g. PKC,
MAPK, Cdk5 or Akt [105].
Heart
In the heart, Kirca et al. suggested that reduced mito-
chondrial Cx43 is associated with a change of NOS iso-
forms leading to reduced NOS activity and - thereby - to
reduced S-nitrosylation of several proteins. However, a
direct S-nitrosylation of Cx43 by NO was not shown in
this study [106], but this effect seems to be important
for the endogenous cardioprotection, which is decreased
in mice lacking Cx43 [107]. A study of Yang et al. dem-
onstrated that the increased risk of arrhythmias in re-
sponse to increased cardiac oxidative stress is associated
with a downregulation of Cx43. Oxidative stress trig-
gered the S-nitrosylation of caveolin 1 (Cav1) by en-
hanced binding of Cav1 to eNOS, which resulted in
the dissociation of S-nitrosylated Cav1 from cSrc/
Cav1 complexes and subsequent phosphorylation of
cSrc. Activated cSrc finally competed with Cx43 and
led to a dislocation of Cx43 from ZO-1 disrupting
the GJs and increasing their internalization [108].
Endothelial cells
Endothelial cells mainly express Cx37, Cx40 and Cx43
[109]. These cells produce NO via activation of the
endothelial NOS (eNOS). NO diffuses via the plasma
membranes into the cytoplasm of smooth muscle cells
inducing their relaxation. In terms of the effect of NO
on GJs formed by these Cxs, it has been shown that NO
modified endothelial cell coupling both in vivo and
in vitro [110–116]. In particular, NO decreased dye
coupling and calcium signal propagation mediated by
GJs containing Cx37 in a cGMP independent manner
[115, 116]. These results were obtained in a heterologous
system (HeLa cells), expressing defined subtypes of Cxs
as well as in cultured vascular cells (endothelial cells and
co-cultures of endothelial cells and smooth muscle cells)
and seem to be important for the modulation of myoen-
dothelial GJs [116]. In agreement with these findings,
another group of researchers reported that electrical
coupling was no longer reduced by NO in endothelial
cells derived from Cx37 knockout mice [110]. Whether
NO acts directly or indirectly upon Cx37 is still un-
known. Both groups [110, 115] showed that membrane
expression of Cx37 was not changed by NO [115] ex-
cluding changes in the membrane incorporation as
shown for Cx40 [112, 117]. In their study, Hoffmann et
al. demonstrated that NO in the long term increased the
insertion of Cx40 into the cell membrane via activation
of cGMP/cAMP dependent kinases [112] therefore lead-
ing to an increase of GJ permeability. This effect could
be mediated either via a phosphorylation of Cx40 by
PKA or indirectly by increasing the incorporation of ves-
icles with Cx40 containing GJ-HCs into the membrane.
NO also led to an increased GJ permeability in vessels
highly expressing Cx43, but in contrast to Cx40, NO
was probably acting directly on Cx43 via S-nitrosylation
of Cys271 within the C-terminus [114].
Because NO is a highly reactive molecule eNOS is ex-
pected to be in very close proximity to Cxs present in
endothelial cells. This was, in fact, observed for at least
Cx37 and Cx40 [118, 119], and both Cxs seemed to be
involved in the basal NO production [120]. For a de-
tailed revision of the effect of NO on endothelial cells,
see also [121].
Brain
By the mid-nineties it was shown in astrocytes that NO
produced by iNOS after LPS exposure, decreased GJIC
in a peroxynitrite anion (ONOO-) dependent manner
[122]. Later on, it could be demonstrated that a down-
regulation of caveolin-3 was additionally required for
this effect [123]. Similarly, in primary cultures of astro-
cytes from streptozotocin (STZ)-diabetic rats (character-
ized by increased levels of reactive oxygen-nitrogen
species) 75 % of these cells were less coupled compared
to non-diabetic astrocytes [124]. Interestingly, the com-
munication between astrocytes was restored by applying
dithiothreitol (DTT) to the bath solution [124], which
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inhibited S-nitrosylation. This suggests that NO induced
the S-nitrosylation of Cx43 (probably the major Cx tar-
get of diabetes) in astrocytes, which in turn decreased
GJIC [124]. However, Retamal and colleagues showed
that the intercellular communication was decreased in
astrocytes exposed to a conditioned media from micro-
glia exposed to LPS or pro-inflammatory cytokines,
which could be restored by inhibition of p38 MAPK but
not by DTT [125]. Therefore, NO might exert its effects
in different ways and through diverse mechanisms that
are not completely understood. However, it remains to
be elucidated whether GJs formed by Cx43 in astrocytes
can be S-nitrosylated both in vitro and/or in vivo.
In the case of neurons, seminal experiments per-
formed by Rörig and Sutor, demonstrated that a NO/
cGMP dependent mechanism decreased GJIC between
neurons within the neocortex [126]. In the developing
brain, GJs - built by at least Cx26 and Cx36 [127] -
were modified by NO/cGMP leading to a reduced
permeability of the intercellular channels GJs [126].
In contrast, in neostriatal neurons NO increased gap
junctional coupling, which was prevented in the pres-
ence of a NO synthase inhibitor [128]. Unfortunately,
the mechanism underlying this effect was not ana-
lyzed in this study. The production of NO can be
stimulated by glutamate that induces a calcium influx
necessary for NOS activation. The modulation of GJs
by NO/cGMP could therefore be a link between glu-
tamatergic synaptic transmission and gap junctional
communication [129]. In HeLa cells transfected with
the neuronal Cx35, NO reduced intercellular coupling
[59]. Two pathways have been suggested: one acting
via the guanylyl cyclase and the other modifying the
PKA activity. Nevertheless, both pathways involve
changes of the phosphorylation at several serines
within the C-terminus of Cx35 [59].
Retina
The retina is a tissue that enables the transduction of
light into information to be processed by the brain
[130]. GJs are essential for the retinal development and
its function and, therefore, all retinal cell types express
at least one Cx subtype [131]. In response to light, rabbit
amacrine cells release dopamine and NO [132]. The acti-
vation of the NO/cGMP/PKG dependent pathway, in-
duced the inhibition of GJIC of horizontal cells of turtle
[133], rabbit [134], goldfish [135] and bass [136], sug-
gesting that both NO and GJIC are involved in the light
adaptation. Similarly, GJIC between AII amacrine and
bipolar cells was moderately decreased after SNAP and
8-Br-cGMP exposition [137]. Therefore, NO modulates
the light processing in the retina through regulation of
the intercellular communication mediated by GJs [137].
Regulation of HCs by nitric oxide
HCs participate in several physiological and patho-
logical processes [138]. For that reason, they are
tightly controlled by several mechanisms, including
the redox potential [95]. In this context, NO appears
to be a very important molecule that rules HC activ-
ity [95]. Thus, in cultured astrocytes, exogenous ap-
plication of the physiological NO-donor GSNO was
associated with an increase in Cx43-HC activity prob-
ably mediated by S-nitrosylation of Cx43 [139]. Fur-
thermore, activated microglia can open Cx43-HCs in
astrocytes in a NO-dependent manner since this effect
was completely blocked by the NOS blocker L-NAME
and also by DTT [125]. Interestingly, DTT is also able to
increase HC activity in both astrocytes and HeLa cells
[140]. These opposing effects of DTT might be explained
by the dependency from the metabolic cell status.
DTT increased the HC activity under control condi-
tions, but decreased the HC activity after at least
40 min of metabolic inhibition [140], indicating that
NO effects are more complex possibly involving
changes in phosphorylation and/or S-nitrosylation of
Cx43 [140]. It has been proposed that S-nitrosylation
in Cx43 HCs could occur at Cys271 as a regulatory
site in Cx43 GJs [114], therefore, it is possible that
this residue is involved in Cx43-HC regulation in-
duced by NO. Experiments with Cx46 showed that
NO is able to modulate the voltage sensitivity, open-
ing/closing kinetics and permeability of Cx46 HCs
[141]. The effect of NO on HCs seems to be
dependent on the Cx type, for example HCs formed
by Cx37, Cx40 and Cx43 can be opened by NO
whereas Cx32 HCs were closed by NO [142].
Not only Cxs but also pannexin channels can be
regulated via NO. An inhibitory effect of NO in a
cGMP/PKG dependent way was demonstrated by
Poornima et al. [143]. They showed that NO donors
reduced Panx1 currents in HEK293 cells and that in-
hibition of the soluble guanylate cyclase or of PKG
blocked the NO effect [143].
Regulation of GJs and HCs by carbon monoxide
CO is a toxic molecule because it binds with high af-
finity to hemoglobin [144, 145]. However, there is a
growing body of evidence showing that CO can be in-
volved as a physiological molecule in several cellular
processes [146]. Thus, CO is produced by heme oxy-
genase enzymes under physiological conditions by de-
composition of heme to biliverdin [147]. Recently, it
has been demonstrated that CO can act as a novel
HC modulator [148, 149]. In a study from León-Para-
vic et al. the application of CO donors (CORM-A1,
CORM-2 and CORM-3) to the bath solution inhibited
Cx46 HC currents in Xenopus laevis oocytes [148].
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This effect was fully prevented by the addition of the
CO scavenger hemoglobin and correlated with Cx46
carbonylation, which in turn, produced important
protein structural rearrangements. Additionally, Cx43-
HCs in HeLa cells were also inhibited by CO donors.
The HC inhibition observed had an IC50 of about
3.4 μM (the physiological concentration is a few mi-
cromolar), making Cx46- and Cx43-HCs to excellent sen-
sors of physiological and pathological changes in CO
concentration [148]. This study further demonstrated that
Cx46-HCs lacking extracellular-loop cysteines were much
less sensitive to CO and that CO induced HC inhibition
was fully recovered by addition of reducing agents to the
bath solution (e.g. GSH or DTT). This suggests that
extracellular-loop cysteines are important for CO induced
Cx46-HC inhibition [148]. So far, there are no additional
reports demonstrating a CO effect on other Cxs and there
is no evidence on CO induced effects upon GJ channels.
However, due to the inhibitory effect of CO on HCs it
might be possible that CO can reduce GJIC probably due
to reduced GJ formation rather than a direct action.
Regulation of GJs and HCs by hydrogen sulfide
Three enzymes are responsible for the formation of
the gaseous transmitter H2S from L-cysteine: cystathi-
onine γ-lyase (CSE), cystathionine β-synthase (CBS),
and 3-mercaptopyruvate sulfurtransferase (3-MST)
[150]. Sulfhydration occurs when H2S reacts with
cysteine residues to form SSH or persulfide groups
[151]. The modification of Cx HC properties by H2S
has not been reported yet. However, it has been
shown that H2S improved the expression of Cx43 in
cardiomyocytes [152], which improves the cardiac
outcome, decreases hypertrophy, and reduces fibrosis.
Additionally, application of H2S decreases platelet ag-
gregation probably by interfering with GJ channels, at
least in part [153].
Conclusions
Changes of environmental conditions, e.g. the presence
of growth factors, cytokines, wounding, ischemic condi-
tions, changes in the redox potential, but also of cellular
processes as cell cycle progression often lead to post-
translational modifications of Cxs. Thus, to respond to
acute changes of environmental or cellular conditions
cells have developed an appropriate mechanism to regu-
late their intercellular communication with neighboring
cells or their communication with the extracellular space
via HCs. The great amount of excellent studies and re-
ports clearly demonstrate the importance of post-
translational changes of Cxs for the regulation of HCs or
intact GJ channels. In the case of phosphorylation, simi-
lar roles regarding the channel permeability have been
described for different Cx types, but there are also some
exceptions, too. The effect on channel permeability of
HCs is consistent with that of GJs after phosphorylation
of Cxs. However, the effect of NO on GJ channels or on
HCs is not unitary. Therefore, it is not possible to estab-
lish a common pattern of action of NO on Cx HCs or
GJ channels. Based on these reports it has been shown
that not only the Cx type is important, but also the dif-
ferent intracellular pathways activated by NO in dif-
ferent types of cells. The complex situation of a
certain cell type and its environment is critical for
the net effect of post-translational modifications and
will also depend on the metabolic cell status and kin-
ase/phosphatase expression under a given condition.
The abundance of literature demonstrate that post-
translational modifications of Cxs are of great import-
ance in modifying HC activity or GJIC and in future
probably additional sites for post-translational modifi-
cations will be identified.
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